European Journal of Clinical Pharmacology

, Volume 19, Issue 4, pp 245–249

Circulatory effects of sublingual and oral sustained-release nitroglycerin in healthy young men

  • G. Nyberg
  • H. Westling


The effects on heart rate and blood pressure during standing, and on plethysmographic arterial pulsation in the calf, of nitroglycerin 0.5 mg sublingually, 6.5 mg orally and a placebo tablet were studied for up to 8 h. Sublingual nitroglycerin increased heart rate and arterial pulsation; the peak height and duration of these effects occurred at slightly different times. Oral nitroglycerin had no effect on heart rate but did increase pulsations as compared to placebo. In the orthostatic test, heart rate and pulse amplitude were affected by both forms of administration. Comparing the areas-under-curve for these variables for the two forms suggested that, in comparison with sublingual nitroglycerin, about 1/3 of the oral nitroglycerin was biologically effective over 8 h. Pulse plethysmography appeared to be the most sensitive method for “bioassay” of nitroglycerin.

Key words

nitroglycerin sublingual oral heart rate blood pressure arterial pulse plethysmography 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bogaert MG, Rosseel MT (1972) Plasma levels in man of nitroglycerine after buccal administration. J Pharm Pharmacol 24: 737–738Google Scholar
  2. Bollinger A, Fromm U, Brunner HH, Mahler F, Casty M, Anliker M, Siegenthaler W (1976) Die Wirkung von Isosorbid-Dinitrat (ISDN) auf den peripheren Kreislauf: Eine Studie mit kontinuierlicher perkutaner Flußmessung in der A. Femoralis. In: Rudolph W, Siegenthaler W (eds) Nitrate. Wirkung auf Herz und Kreislauf. Urban & Schwarzenberg, München, pp. 54–61Google Scholar
  3. Goodman LS, Gilman A (1975) The pharmacological basis of therapeutics, 5th edn. MacMillan, New YorkGoogle Scholar
  4. Goth A (1976) Medical pharmacology, 8th edn. C V Mosby, St. LouisGoogle Scholar
  5. Hunyor S, Nyberg G (1978) Comparison of intraarterial and indirect blood pressures at rest and during isometric exercise in hypertensive patients before and after metoprolol. Br J Clin Pharmacol 6: 109–114Google Scholar
  6. Johnsson G, Regårdh C-G (1976) Clinical pharmacokinetics of adrenoreceptor blocking drugs. Clin Pharmacokinet 1: 233–263Google Scholar
  7. Jonson B, Nilsen R (1969) Venous pulsations in the upper arm studied with plethysmographic technique. Scand J Clin Lab Invest 24: 131–140Google Scholar
  8. Jonson B, Nilsén R, Ohlin P, Westling H (1976) Nitroglycerine: A drug producing pharmacologic counterpulsation? Abstracts 7th Eur Congr Cardiol (Amsterdam) II: 417Google Scholar
  9. Needleman P, Lang S, Johnson EM (1972) Organic nitrates: relationship between biotransformation and rational angina pectoris therapy. J Pharmacol Exp Ther 181: 489–497Google Scholar
  10. Nilsén R (1970) On the clinical use of pulse plethysmography of the calf. Scand J Clin Lab Invest 25: 1–10Google Scholar
  11. Nordenfelt I, Westling H (1967) A note on the haemodynamic effects of nitroglycerine and related substances in normal subjects. Acta Med Scand (suppl) 472: 81–87Google Scholar
  12. Nyberg G (1977) Indirect blood pressure and heart rate measured quickly without observer bias using a semi-automatic machine (Auto-Manometer) — response to isometric exercise in normal healthy males and its modification by beta-adrenoceptor blockade. Br J Clin Pharmacol 4: 275–281Google Scholar
  13. Nyberg G (1978) Effects on heart rate and blood pressure of sublingual nitroglycerin at rest and during sustained handgrip in patients with arterial hypertension. Curr Ther Res 23: 306–311Google Scholar
  14. Nyberg G (1979) Effects of beta-receptor antagonists (metoprolol, pindolol), beta2-receptor agonist (terbutaline) and nitroglycerine (sublingual and oral slow-release) on the blood pressure reaction during isometric exercise in patients with angina pectoris. Curr Ther Res 25: 389–399Google Scholar
  15. Smolen VF (1979) Bioavailability and pharmacologic activity of oral and topical long-acting nitroglycerine. Clin Res 27: 546 AGoogle Scholar
  16. Warren SE, Francis GS (1978) Nitroglycerine and nitrate esters. Am J Med 65: 53–62Google Scholar
  17. Winsor T, Berger HJ (1975) Oral nitroglycerine as a prophylactic antianginal drug: Clinical, physiological and statistical evidence of efficacy based on a three-phase experimental design. Am Heart J 90: 611–626Google Scholar
  18. Winsor T, Kaye H, Mills B (1972) Hemodynamic response of oral long-acting nitrates: evidence of gastrointestinal absorption. Chest 62: 407–413Google Scholar

Copyright information

© Springer-Verlag 1981

Authors and Affiliations

  • G. Nyberg
    • 1
  • H. Westling
    • 2
  1. 1.Department of MedicineÖstra HospitalGöteborgSweden
  2. 2.Department of Clinical PhysiologyLasarettet, LundSweden

Personalised recommendations